-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Freeline Therapeutics Holdings plc annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2018 to 2022.
- Freeline Therapeutics Holdings plc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2022 was $25.2M.
- Freeline Therapeutics Holdings plc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $27.5M.
- Freeline Therapeutics Holdings plc annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$984K, a 100% decline from 2020.
- Freeline Therapeutics Holdings plc annual Net Cash Provided by (Used in) Financing Activities for 2020 was $243M, a 112% increase from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)